BAP1 C91S

CI-VAR-00000368Explore in graph →CIViC 3756

Curated evidence

Evidence by cancer (1 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–1 of 1 evidence items across 1 cancer context on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
Unmapped disease1unmapped disease
BAP1 C91S	(functional)	Functional	D	Supports Dominant Negative	2	submitted	EID10210 The deubiquitinating enzyme BAP1 was overexpressed in MCF10A and MCF12A cells to assess the effects on cell growth. Expression of the C91S mutant inhibited cell growth while wild-type BAP1 did not. BA… (full text at CIViC) PMID 19815555 · Machida et al., 2009 · Open in CIViC	civic

ClinVar

Clinical significance (0)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

Data not yet available

No ClinVar interpretation attached to this variant.